Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-interventional Registration Study of Monotherapy or Combination Regimens Based on Camrelizumab or Famitinib for the Treatment of Cervical Cancer

NCT07266350 is registered in ClinicalTrials.gov with Qi Zhou as lead sponsor.

NCT NCT07266350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07266350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-interventional Registration Study of Monotherapy or Combination Regimens Based on Camrelizumab or Famitinib for the Treatment of Cervical Cancer
Lead sponsor
Qi Zhou
Phase
Observational
Overall status
Not yet recruiting
Start date
December 30, 2025
Completion date
December 30, 2030
Enrollment
1,300 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer metastatic, cervical cancer recurrent